EDIT:NASDAQ
Editas Medicine Inc
$2.17
arrow_upward
+1.40%(+0.030) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.14
High
$2.21
Low
$2.01
Mkt. cap
334.92M
Avg. vol.
2.42M
Volume
2.79M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
Open
$2.14
High
$2.21
Low
$2.01
Mkt. cap
334.92M
Avg. vol.
2.42M
Volume
2.79M
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.62
Beta
2.09
Shares outstanding
154.34M
No. of employees
87
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
BigGo Finance
·
7 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
The Motley Fool
·
6 hours ago
Tesla Is Down 13% in 2026 While the S&P 500 Is Up. Here’s the 1 Catalyst Left This Year That Could Flip That.
Traders Union
·
4 hours ago
Chris Ciovacco: Semiconductors SMH and S&P 500 SPY show several possible support areas
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees87
FoundedNov 2013
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteeditasmedicine.com